A Study of Revaree Plus in People With Breast Cancer

NCT07042581 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Stage 0 Breast Cancer
Stage I Breast Cancer
Stage II Breast Cancer
Stage III Breast Cancer
Stage 0 Breast Carcinoma
Stage II Breast Carcinoma
Stage III Breast Carcinoma
Hormone-receptor-positive Breast Cancer
Hormone Receptor Positive Breast Carcinoma
Hormone Receptor Positive Malignant Neoplasm of Breast

Interventions

DRUG: Revaree Plus

Sponsor

Memorial Sloan Kettering Cancer Center